Atazanavir: a novel inhibitor of HIV-protease in haemodialysis.
Izzedine
Hassane
H
Launay-Vacher
Vincent
V
Peytavin
Gilles
G
Valantin
Marc Antoine
MA
Deray
Gilbert
G
D000069446:Atazanavir Sulfate; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011725:Pyridines / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006435:Renal Dialysis
D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate